Clinical Trials Browser

OTHER × Carcinoma, Non-Small-Cell Lung × HM781-36B × Clear all

NCT03066206 2026-02-20

Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC

Phase 2 Terminated

Carcinoma, Non-Small-Cell Lung

NCT05045404 2023-09-13

Poziotinib and Ramucirumab for the Treatment of EGFR Exon 20 Mutant Stage IV Non-small Cell Lung Cancer

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms